Latest Ketones Stories
PSP Working with Departments of Health and Drug & Alcohol Programs to Make Naloxone Available to First Responders HARRISBURG, Pa., April 7, 2015 /PRNewswire-USNewswire/ -- The Wolf
Programs encouraging appropriate use of painkillers could improve safety, reduce costs ST.
JUPITER, Fla., April 6, 2015 /PRNewswire/ -- Charleston Laboratories, Inc.
The Firm’s new website, ZofranCenter.com, was launched to provide the public with updated information regarding growing litigation involving an alleged association between Zofran and birth defects.
DeepResearchReports.com announces Global Acetone Industry 2015 Market Research Report of 199 pages and Global Inositol Industry 2015 Market Research Report of 108 pages added to its research database.
In the news release, Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020, issued 01-Apr-2015 by Egalet Corporation over PR Newswire, we
WAYNE, Pa., April 1, 2015 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing
Robert Gardner Law has created a new resource site to investigate claims following a U.S. Justice department criminal plea agreement with GlaxoSmithKline.
WILMINGTON, Del., March 31, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) reported that partner AstraZeneca announced today that MOVANTIK(TM) (naloxegol) has launched in the United States.
In response to this and other recent Zofran lawsuit filings, Bernstein Liebhard LLP has launched an investigation into allegations that the anti-nausea medication may cause birth defects when
- Growing in low tufty patches.
More Images (1 images) »